Melodiol Global Health Limited

ME1

AU0000282840

Pharmaceuticals

Market Closed - Australian S.E. Other stock markets 07:10:06 16/07/2024 BST			5-day change	1st Jan Change
0.002 ^AUD	0.00%		0.00%	-99.83%

05-09	Melodiol Global's Mernova Unit Launches More Products; Shares Jump 50%	MT
04-16	Melodiol Global's Revenue Surges 79% in Q1	MT

Creso Pharma (ASX:CPH) signs agreement with Swiss food and pharma company Domaco

March 07, 2017 at 11:20 pm

Medicinal cannabis provider Creso Pharma (ASX:CPH) CEO, Dr Miri Halperin Wernli discusses its hemp extract licencing agreement with Domaco, Dr. med. Aufdermaur AG.

The agreement with Domaco is for the development, the manufacture and commercialisation of two new second generation cannabinoid nutraceutical products for use in human health.

Domaco is a traditional Swiss, high tech food and pharma company in business since 1922. It is a leading European producer of innovative products both for global pharmaceutical and global food companies.

The agreement also includes the development of new animal health nutraceutical products for companion animals, with a novel delivery technology.

Creso Pharma will retain all of the IP rights for all of the developed products.

Latest news about Melodiol Global Health Limited

Melodiol Global's Mernova Unit Launches More Products; Shares Jump 50%	05-09	MT
Melodiol Global's Revenue Surges 79% in Q1	04-16	MT
Melodiol Global Health Subsidiary Health House Australia to Launch Medicinal Cannabis Clinic	04-09	MT
Melodiol Global Health Posts 148% Increase in FY 2023 Revenue to AU$21.6 Million	03-26	MT
Melodiol Global Health Limited Reports Earnings Results for the Full Year Ended December 31, 2023	02-29	CI
Melodiol Unit to Add Cannabis Products Across Six Canadian Provinces	02-13	MT
Melodial's Unit Logs AU$1 Million Revenues in January	02-07	MT
Melodiol Global Health Limited Announces Resignation of Erlyn Dawson as Joint Company Secretary	12-21	CI
Melodiol Global Health Limited Reports Unaudited Revenue Results for the Nine Months of 2023	11-12	CI
Melodiol Global's Canadian Arm Mernova Posts Record Sales for October	11-02	MT
Melodiol Global Health Achieves 80% Remission Rate from Phase Two Hallucinogenic Trial	12/10/23	MT
Melodial's Canadian Arm Mernova Logs Record Sales in Q3	10/10/23	MT
Melodiol Global Health Limited Reports Earnings Results for the Half Year Ended June 30, 2023	31/08/23	CI
Panacea Life Sciences Holdings, Inc. entered into a non-binding LOI to acquire Sierra Sages Herbs, LLC and Halucenex Life Sciences Inc. for $20 million.	01/08/23	CI
Melodiol Logs Strong Start to Q3 with AU$1.6 Million in Revenue and Confirmed Purchase Orders	20/07/23	MT
Melodiol Global Health Limited Announces Revenue Results for Third Quarter of 2023	19/07/23	CI
Melodiol Global Health Triples Q2 Net Sales	13/07/23	MT
Creso Pharma Changes Name to Melodiol Global Health	13/06/23	MT
Creso Pharma Signs Deal to Import Psychedelic Medication into Australia	09/06/23	MT
Creso Pharma's Subsidiary Hires Consultant to Support Licensing Process in Australia, Europe	05/06/23	MT
Creso Pharma Raises AU$2.5 Million Via Share Issue	19/05/23	MT
ASX Halts Creso Pharma's Trading Amid Pending Announcement	18/05/23	MT
Health House International to be Removed from Australian Bourse's Official List	17/05/23	MT
Creso Pharma Limited completed the acquisition of Health House International Limited.	15/05/23	CI
Creso Pharma Expands Pet Care Range to Asia with Distribution Deals	15/05/23	MT

Chart Melodiol Global Health Limited

Duration

Period

More charts

Company Profile

Melodiol Global Health Limited is an Australia-based cannabis company. The Company develops cannabis, hemp-derived and other plant-based therapeutic, nutraceutical, and lifestyle products. The Company distributes pharmaceuticals internationally, specializing in the distribution of medicinal cannabis products across Australasia, and non-cannabis products in the United Kingdom and Europe. It also develops and sells beauty and personal care products, produced using plant-based processes, including under the brands Green Goo, Southern Butter and Good Goo. Its segments include Europe, Canada and Asia Pacific. Its Europe segment includes Health House International Limited (HHI), UK division, which distributes pharmaceutical products, and Creso Pharma Switzerland GmbH, which includes the development and commercialization of its nutraceutical products located in Switzerland. Its Canada segment includes Mernova Medicinal Inc, a producer of cannabis products and sells under the Ritual brand.

Sector

Pharmaceuticals

Calendar

27/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
MELODIOL GLOBAL HEALTH LIMITED	-99.83%	415K
ELI LILLY AND COMPANY	+61.53%	856B
NOVO NORDISK A/S	+38.95%	631B
JOHNSON & JOHNSON	-3.66%	359B
MERCK & CO., INC.	+15.06%	325B
ABBVIE INC.	+9.18%	297B
ROCHE HOLDING AG	+5.89%	234B
NOVARTIS AG	+16.53%	226B
AMGEN INC.	+15.67%	177B
PFIZER, INC.	+2.47%	165B